For Physicians
- Recognize the importance of LDL-C in the genesis and progression of
atherosclerosis
- Improve cardiovascular outcomes by appropriately stratifying the high
risk and very high-risk population
- Avoid delay in therapy initiation for primary and secondary prevention
- Avoid discontinuation of ASCVD medication for all patients
- Highlight the gaps in medical education regarding ASCVD
- Identify patients with high LDL-C and perform appropriate treatment
and follow up, reinforcing the proper use of hypolipidemic agents in
ASCVD at risk populations
- Dispel myths associated with dangers of very low LDL-C levels and
lipid lowering therapy
- Recognize which patients need to be referred to specialists